All lobbying filings

STEPTOE LLP

Lobbying for OREXO US, INC. · Pharmaceuticals / health products

Filing Registration

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Mar 4, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New Jersey

Official filing document

Lobbyists on this filing 2

ROWAN BOST New on this filing

Previously held: Legislative Aide, Office of Senator Susan Collins; Legislative Correspondent, Office of Senator Susan Collins; Intern, Office of Senator Susan Collins; Senate Page, Senator Olympia Snowe
MATTHEW FLYNN New on this filing

Previously held: Mbr-HSAC; Dep Asst Sec Def-DOD; Couns, L&M Mgmt-DOI; Dep Asst to the Pres & Acting WH Cabinet Sec., Dep Cabinet Sec., Special Asst to the Pres, Sr. Dir. for Cabinet Affairs-EOP; Sr Adv.-State; LC/Dep Health Counsel, Intern-House

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 2

Alcohol and Drug Abuse

Advocacy on xylazine and adultered-opioid overdose solutions and federal funding.

Budget/Appropriations

Advocacy on xylazine and adultered-opioid overdose solutions and federal funding.

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

OREXO AB

Switzerland · Uppsala · owns 100% of the client · contributed $0.00

Affiliated organizations 1

Section 6 of the LD-2: organizations that contribute to this lobbying or take an active part in directing it. On a trade association's filing, this is where its backers appear.

OREXO AB

Uppsala · Switzerland

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.